Teresa Coleman, MD, FACP Physician



Bachelors

Armstrong State College Savannah Georgia

Medical School

Medical College of Georgia Augusta Georgia

Internship & Residency

Categorical Medicine Eisenhower Army Medical Center Ft. Gordon Augusta GA

Fellowship

Oncology Brooke Army Medical Center San Antonio TX

Fellowship

Hematology Brooke Army Medical Center San Antonio TX

Medical Oncology

Board Certified, American Board of Internal Medicine

Internal Medicine

Board Certified, American Board of Internal Medicine

Hematology

Board Certified, American Board of Internal Medicine

Research Presentations

  1. DYNAMO?: A phase 2 trial of the PI3K- δ, γ inhibitor IPI- 145 in patients with refractory indolent non-Hodgkin lymphoma. Wagner-Johnston N , Strickland DK, Wright DD, Tetreault SA, Lunin SD, Essell JH, Webb CD, Langdon RM, . Farber CM , Nimeh NF, Marris M, Coleman TA, Kelly PF, Steelman L, Dewar K, Pimental P, Flinn I. Clin Oncol 32:5s, 2014 (suppl; abstr TPS8619) ASCO 2014
  2. Acute pancreatitis and obstructive jaundice secondary to Diffuse Large B-Cell Lymphoma. Gangireddy V, Biju A, Coleman T. Poster Presentation at American College of Gastroenterology Meeting 2011
  3. Management of Thrombocytopenia in a patient with Autoimmune hepatitis. Gangireddy V, Coleman T. Poster Presentation at American College of Gastroenterology Meeting 2011
  4. Pleiotropic Effects of Simvastatin on Prostate Cancer Growth. Kochuparambil T, Al-Husein B, Soliman S, Goc A, Coleman T, Terris M, Shenoy S. Poster Presentation at American Urologic Association Meeting 2011
  5. Report of a Peri-Ocular Merkel Cell Carcinoma treated with Primary Concomitant Chemotherapy and Radiation, and Review of the Literature regarding its use. Prosser D, Coleman TA, Jackson LA. . Poster presentation at the Triological Society Combined Sections Meeting 2010
  6. Women in Medicine at the Medical College of Georgia (MCG) School of Medicine forming a Network of Women Physicians and Resources to Promote the Career Success of Both Faculty and House Staff In Transition. A.D. May, T.A. Coleman, L.A. Mulloy, M. McGettigan, R.M.E. Fincher. Poster Presentation AAMC 2009
  7. Health Status of Offspring Conceived During Parents Hydroxyurea Therapy. Tanna S, Kutlar A, Coleman T, Ustun C. Poster Presentation at the American Society of Hematology(ASH) 2009 annual meeting.
  8. Relationship Of Fdg Pet-Ct Suv Values And Accuracy In Head And Neck Squamous Cell Cancer Surveillance. Adkins L, Weinberger P, Coleman T, Williams H, Terris D. Oral presentation- Eastern Atlantic Student Research Forum sponsored by the AMA, February 26, 2009.
  9. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Gourin C, Conger B, Sheils C, Bilodeau P, Coleman T, Porubsky P. Oral presentation at the7th International Meeting of the American Head and Neck Society, San Francisco, CA, July 21, 2008
  10. Use of PET-CT to Identify Metastases in Head and Neck Cancer. Watts T, Gourin C, Opraseuth J, Williams H, Patel V, Coleman T, Bilodeau P. Oral Presentation- Annual Meeting of the American Academy of Otolaryngology-Head and Neck Surgery Foundation 2007
  11. Renal Mass and Paracaval Node: Sagar R. Shah1, Teresa Coleman2, Jeremy Miller3, Martha K. Terris1. Oral Presentation- Georgia Urological Association annual meeting 2007
  12. Fever of Unknown Origin in a Soldier returning from Italy. Pantsari M, Coleman T. New England Journal of Medicine 349:14, 2003. Oral Presentation/second place winner of the associates’ oral competition – Georgia American College of Physicians meeting 2002.
  13. Pseudohyponatremia and Hyperproteinemia Predict Hyperviscosity following Intravenous Immunoglobulin Therapy. Steinberger BA, Ford SF, Coleman TA. Blood 98; 111(4090a) 2001. Poster presentation/ first place winner of the associates’ poster competition - 18th Annual Army American College of Physicians meeting 2001.
  14. Low dose Warfarin decreases central line thrombosis and tissue plasminogen activator (TPA) Utilization in cancer patients but does not improve Overall Survival. Macareo LM, Ford SF, Crocker JD, Coleman TA. Blood 98; 94-95 (4013a) 2001.Oral presentation- 18th Annual Army American College of Physicians meeting 2001.
  15. Salvage Chemotherapy Significantly Prolongs Survival in Patients with Breast Cancer Who Relapse after High Dose Chemotherapy. Waselenko J, Caton J, Atkins MY, Vulkelja S, Coleman T, Myhand R. Blood 94: 10 (Suppl 1), 1572a, 353, 1999.

Poster Presentation – ASH (American Society of Hematology) 1999.

  1. Infusional Paclitaxel Induces Rapid Liver Transaminase Elevations In-Patients with Metastatic Breast Cancer Receiving Paclitaxel. Cisplatin and Cyclophosphamide (PCC) with Autologous Peripheral Blood Stem Cell Support (PBSCS). R. Myhand, S. Vukelja, T. Coleman, J. Waselenko, Bone Marrow Transplant Service, Brooke Army Medical Center, San Antonio, TX and Tyler Cancer Center, Tyler, TX, USA. Blood 92 : 10 (suppl 1), 1127a, 1998.Poster Presentation - ASH 1998
  2. L-Selection (CD62L) as a Measure of Viability During Prolonged Neutrophil (PMN) Storage. T. Coleman, M. Bradley, R. Bowden, E. Ayala, R. Hensley and D. Anderson. Division of Hematology, Brooke Army Medical Center, San Antonio, TX: Division of Pathology, Wilford Hall Medical Center, San Antonio, TX, USA. Blood, 92:10 (suppl 1), 3161a, 1998. Oral Presentation - 14th Annual Army ACP 1998
  3. Autologous Granulocyte Storage and Infusion as Supportive Care In-Patients Receiving High Dose Chemotherapy with Stem Cell Support. R. Myhand, J. Stephenson, T. Coleman, E. Ayala. Brooke Army Medical Center, Bone Marrow Transplant Service, San Antonio, TX. Blood 88:10 (suppl 1), 1651a, 1996. Poster Presentation - ASH 1996

Abstracts

  1. DYNAMO?: A phase 2 trial of the PI3K- δ, γ inhibitor IPI- 145 in patients with refractory indolent non-Hodgkin lymphoma. Wagner-Johnston N , Strickland DK, Wright DD, Tetreault SA, Lunin SD, Essell JH, Webb CD, Langdon RM, . Farber CM , Nimeh NF, Marris M, Coleman TA, Kelly PF, Steelman L, Dewar K, Pimental P, Flinn I. Clin Oncol 32:5s, 2014 (suppl; abstr TPS8619)
  2. Case report of periocular Merkel cell carcinoma treated with primary concomitant chemotherapy and radiation, and review of the literature regarding its use.Prosser JD, Bhatt N, Coleman T, Jackson L.Laryngoscope. 2010;120 Suppl 4:S177.
  3. A phase I study of the novel DNA topoisomerase-1 inhibitor, TLC388 (Lipotecan), administered intravenously to patients with advanced solid tumors. S. A. Ghamande SA , Lin CC, Cho DC, Coleman TA , Chaudhary I, Cleary JM, Silverman MH, Kuo MW, Mach W, Tseng Y, Hsu SC , Goel S. Abstr# 85097, ASCO 2011.
  4. Simvastatin and docetaxel utilizes different molecular pathways in the regulation of cell survival and apoptosis in prostate and breast cancer cells; Kochuparambil T, Al-Husein B, Goc A, Mohammad S, Terris M, Samuel, T, Coleman T, and Shenoy S. ASCO 2011.
  5. Factors predicting a response to anti-androgen withdrawal maneuvers in prostate cancer patients failing combined androgen blockade. M. M. El Geneidy, G. Lewis, P. Dainer, M. K. Terris, J. Brown, T. Coleman. J Clin Oncol 26: 2008 (May 20 suppl; abstr 16116).
  6. Use of PET-CT to Identify Metastases in Head and Neck Cancer. Watts T, Gourin C, Opraseuth J, Williams H, Patel V, Coleman T, Bilodeau P. Otolaryngology-Head and Neck Surgery 137:1;69-70, 2007.
  7. Pseudohyponatremia and Hyperproteinemia Predict Hyperviscosity following Intravenous Immunoglobulin Therapy. Steinberger BA, Ford SF, Coleman TA. Blood 98; 111(4090a) 2001.
  8. Low dose Warfarin decreases central line thrombosis and tissue plasminogen activator (TPA) Utilization in cancer patients but does not improve Overall Survival. Macareo LM, Ford SF, Crocker JD, Coleman TA. Blood 98; 94-95 (4013a) 2001.
  9. Post Transplant Relapse Salvage Chemotherapy with Vinblastine, Mitoxanthrone, Thiotepa, and Halotestin (VMTH) in Patients with Metastatic Breast Cancer. Myhand RC, Waslenko JK, Coleman TA, Waddell JA. Blood 94:10 (Suppl 1), 5029a, 403, 1999.
  10. Salvage Chemotherapy Significantly Prolongs Survival in Patients with Breast Cancer Who Relapse after High Dose Chemotherapy. Waselenko J, Caton J, Atkins MY, Vulkelja S, Coleman T, Myhand R. Blood 94: 10 (Suppl 1), 1572a, 353, 1999.
  11. Tandem Transplantation with Melphalan is Inferior to Tandem Transplant with Cyclophosphamide, Etoposide and Carboplatin (CEC) In-Patients with Metastatic Breast Cancer. R. Myhand, T. Coleman, M. Atkins, J. Waselenko, G. Preston, S. Vukelja. Bone Marrow Transplant Service, Brooke Army Medical Center, San Antonio, TX: Tyler Cancer Center, Tyler, TX, Proc. ASCO, 237a, 1999.
  12. Infusional Paclitaxel Induces Rapid Liver Transaminase Elevations In-Patients with Metastatic Breast Cancer Receiving Paclitaxel. Cisplatin and Cyclophosphamide (PCC) with Autologous Peripheral Blood Stem Cell Support (PBSCS). R. Myhand, S. Vukelja, T. Coleman, J. Waselenko, Bone Marrow Transplant Service, Brooke Army Medical Center, San Antonio, TX and Tyler Cancer Center, Tyler, TX, USA. Blood 92:10 (suppl 1), 1127a, 1998.
  13. L-Selection (CD62L) as a Measure of Viability During Prolonged Neutrophil (PMN) Storage. T. Coleman, M. Bradley, R. Bowden, E. Ayala, R. Hensley and D. Anderson. Division of Hematology, Brooke Army Medical Center, San Antonio, TX: Division of Pathology, Wilford Hall Medical Center, San Antonio, TX, USA. Blood, 92:10 (suppl 1), 3161a, 1998.
  14. The Role of Soluble L-Section (sL-Selection) in Predicting Neutrophil Engraftment Following Autologous PBSCT. Y. Hong, T. Coleman, E. Ayala, Division of Hematology, Brooke Army Medical Center, San Antonio, TX, USA. Blood 92:10 (suppl 1), 4576a, 1998.
  15. Tandem High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Support in Metastatic Breast Cancer. R. Myhand, M. Atkins, T. Coleman et al Bone Marrow Transplant Service, Clinical Investigations and Pathology, Brooke Army Medical Center, San Antonio, TX: Tyler Cancer Center, Tyler, TX. Blood 90:10 (suppl 1), 4571a, 1997.
  16. Autologous Granulocyte Storage and Infusion as Supportive Care In-Patients Receiving High Dose Chemotherapy with Stem Cell Support. R. Myhand, J. Stephenson, T. Coleman, E. Ayala. Brooke Army Medical Center, Bone Marrow Transplant Service, San Antonio, TX. Blood 88:10 (suppl 1), 1651a, 1996.

Book Chapters

1. Coleman TA, Buckley PF, Fincher RM. Developing a Career in Academic Medicine. In “Leadership Careers in Medical Education”, ed by L Pangaro ACP Press 2010. 73-98.

Publications

  1. A phase 1 open label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics if intravenous TLC 388 administered to patients with advanced solid tumors. Ghamande S, Lin CC, Cho DC, Shaprio GI, Kwak EL, Silverman MH, Kuo MW, Mach WB, Hsu SC, Coleman TA. Investigational New Drugs 2014 Jun; 32:445-51.
  2. Images in clinical medicine: Congenital melanocytic nevus. N Engl J Med. Gangireddy VG, Coleman T. 2013 Jul 18;369(3):264.
  3. Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.Gangireddy VG, Coleman TA, Nabh A, Sridha Dig Dis Sci. 2012 Sep;57(9):2466-72. doi: 10.1007/s10620-012-2302-5.
  4. Carcinomatous Menigitis: The natural history of successfully treated metasttic bladder cancer. Tadepalli S, Coleman T, Hacket L, Liles G. Case Reports in Oncology 2011;4(2):406-412.
  5. Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.Gangireddy Vg, Liles GB, Sostre GD, Coleman T. Clin Genitourinary Cancer. 2012 Jun;10(2):134-9.
  6. Cefipime neurotoxicy despite renal dose adjusting. Gangireddy V, Mitchell L, Coleman T. Scandanavian Journal of Infectious Diseases 2011 Oct;43(10):827-9. Epub 2011 May 23.
  7. Utility of (18)F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. Rosevear HM, Williams H, Collins M, Lightfoot AJ, Coleman T, Brown JA.Urol Oncol. 2011 Mar 9. [Epub ahead of print]
  8. Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma. La Vine DBT, Coleman TA, Davis CH, Carbonell CE, Davis WB. Am J Clin Oncol. 2010 Jun;33(3):217-20.
  9. Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: case report and review of the literature. Parikh J, Coleman T, Messias N. Rare Tumors 2009 1 (2): 91-93.
  10. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA. Laryngoscope. 2009 Nov;119(11):2150-5.
  11. Hepatic Failure Due to Plasma Cell Infiltration of the Liver in Multiple Myeloma. Rahhal FE, Schade RR, Nayak A, Coleman TA. World J of Gastroenterol 2009; 15:2038-40.
  12. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Gourin CG, Conger BT, Sheils CW, Biklodeau PA, Coleman TA, Prorubsky ES. Laryngoscope. 2009 Jul;119(7):1312-7.
  13. Leveraging Your Leadership Portfolio: Summary and Review of the AAMC Women in Medicine Plenary Session. Coleman TA. SELAM International 10;11-12, 2008.
  14. Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. Gourin CG, Watts TL, Williams HT, Patel VS, Bilodeau PA, Coleman TA. Laryngoscope. 2009 Apr;119(4):703-6.
  15. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma. Gourin CG, Conger BT, Porubsky ES, Sheils WC, Bilodeau PA, Coleman TA. Laryngoscope 2008 Jul;118(7):1191-4.
  16. Identification of Distant Metastases With Positron-Emission Tomography-Computed Tomography in Patients With Previously Untreated Head and Neck Cancer. GourinCG, Watts TL, Patel VS, Bilodeau PA, Coleman TA. Laryngoscope. 2008 Jan 14 [Epub ahead of print]
  17. A Rectal Adenocarcinoma with Germ Cell Differentiation: Report of a Case. Coleman TA, Redger CD, Hamill RL, Dainer P. Diseases of the Colon and Rectum 46:1702-1705, 2003.
  18. Images in Clinical Medicine: Kala- Azar as a cause of fever of unknown origin. Pantsari M, Coleman T. New England Journal of Medicine 349:14, 2003.
  19. Intravenous Immunoglobulin Therapy Results in Post-infusional Hyperproteinemia, Increased serum Viscosity, and Psuedohyponatremia. Steinberger BA, Ford SM, Coleman TA. American Journal of Hematology 73:97-100, 2003.
  20. Abciximab- associated pseudothrombocytopenia. Wool RL, Coleman TA, Hamill RL. American Journal of Medicine 113:697-698, 2002.
  21. Idiopathic Thrombocytopenic Purpura in a 101 year old Female. Chung KK, Macereo LR, Coleman TA. Annals of Internal Medicine 135: 70-71, 2001.
  22. Erythroleukemia following Erythropoietin therapy, Extramedullary Hematopoiesis, and Splenectomy in a patient with Myelofibrosis and Myeloid Metaplasia. Coleman TA, Hamill RL, Ford SM. American Journal of Hematology 67: 214-215, 2001.
  23. Multiple Complications of IVIG Therapy in a Patient with Guillian-Barre Syndrome. Steinberger BA, Coleman TA. American Journal of Hematology 67:59, 2001.
  24. Clinical Response to unintended infusion of doxorubicin and Vincristine over one instead of 4 days. Waddell A, Coleman T. Am J Health –Syst Pharm; 57: 1242, 2000.


Do you see information that needs to be updated on this page? Click here to let us know.

Have you had a positive experience with Teresa Coleman, MD, FACP? Click here to tell us about it!